businesspress24.com - Healthcare & Medical: Pressemitteilungen - Kategorie - Seite 7
 
PresseMitteilungen

Healthcare & Medical

Category / Healthcare & Medical

Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson Disease

BETHESDA, MD,: Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease ...

Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation

HONG KONG: HONG KONG, Mar 7, 2025 - (ACN Newswire) - Everest Medicines' stock (1952.HK) surged today, opening higher and maintaining strong momentum throughout the trading day. By market close, the stock ha ...

HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open

ROCKVILLE, MD and SHENZHEN: – Data from the proof-of-concept study showed berberine ursodeoxycholate was generally well tolerated and had beneficial therapeutic effect in improving glycemic, hepatic and cardiometabolic paramet ...

Giftify, Inc. Announces Smart Savings Solution for Popular GLP-1 Diabetes and Weight Loss Medications

Schaumburg, Illinois,: CardCash.com to Offer Cost-Effective Solutions for High-Demand GLP-1 Medications as Prescription Drug Market Grows ...

Goldman Sachs Raises Everest Medicines Target Price to HK$48.32 on Stronger Commercial and R&D Outlook

HONG KONG: HONG KONG, Feb 19, 2025 - (ACN Newswire) - Goldman Sachs’ latest report on China’s biotechnology sector highlights Everest Medicines (1952.HK) as a company on track to achieve EBITDA break-even by ...

Olympus Recognized on CDP "A List", the Highest Rating in the Field of Climate Change

TOKYO: TOKYO, Feb 10, 2025 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people's lives healthier, safer and more fulfilling, today announced it has been ...

Where is the next Chinese drug that will make MNCs compete to grab orders?

HONG KONG: HONG KONG, Jan 9, 2025 - (ACN Newswire) – The trading of TCE (T Cell Engager) bispecific antibodies remains hot, and multinational pharmaceutical companies (MNCs) are still placing orders franticall ...

Everest Medicines Announces the Implementation of NEFECON National Reimbursement Drug List Pricing in China for the Treatment for IgA Nephropathy

SHANGHAI: SHANGHAI, China - January 2, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the discovery, clinical d ...

Worlds first high-standard negative-pressure isolation ward built with MiC technology completes historical mission

HONG KONG: Laid solid foundation for modular design in isolation facility construction technology ...

Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive Year

TOKYO: TOKYO, Dec 24, 2024 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced that it has be ...

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY

Shanghai: - by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis ...


Page 7 von 304:  1 « ..  6 7 8  9  10  11  12  13  14  15  .. » 304





 

Who is online

All members: 10 721
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 198


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.